Literature DB >> 6334516

Binding of human blood-coagulation Factors IXa and X to phospholipid membranes.

K Mertens, R Cupers, A Van Wijngaarden, R M Bertina.   

Abstract

A simple centrifugation technique has been developed to study the interaction of human coagulation Factors IXa and X with phospholipid membranes. In the presence of Ca2+, equimolar phosphatidylserine/phosphatidylcholine membranes form tight complexes with Factor X (KD = 2.8 X 10(-8) M); the KD is independent of the phospholipid concentration. Binding sites are available for about 2 mmol of Factor X/mol of phospholipid. Factor IXa has a slightly higher affinity for the phospholipid membrane (KD = 1.2 X 10(-8)M), and competes with Factor X for binding. The experimentally observed competition between Factor X and Factor IXa is in agreement with a model that describes the binding of two distinct ligands to a single class of independent binding sites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6334516      PMCID: PMC1144342          DOI: 10.1042/bj2230599

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Light scattering and turbidity measurements on lipid vesicles.

Authors:  C S Chong; K Colbow
Journal:  Biochim Biophys Acta       Date:  1976-06-17

Review 2.  Vitamin K-dependent formation of gamma-carboxyglutamic acid.

Authors:  J Stenflo; J W Suttie
Journal:  Annu Rev Biochem       Date:  1977       Impact factor: 23.643

3.  Titration of activated bovine Factor X.

Authors:  R L Smith
Journal:  J Biol Chem       Date:  1973-04-10       Impact factor: 5.157

4.  The determination of the concentration of hydrolytic enzyme solutions: alpha-chymotrypsin, trypsin, papain, elastase, subtilisin, and acetylcholinesterase.

Authors:  M L Bender; M L Begué-Cantón; R L Blakeley; L J Brubacher; J Feder; C R Gunter; F J Kézdy; J V Killheffer; T H Marshall; C G Miller; R W Roeske; J K Stoops
Journal:  J Am Chem Soc       Date:  1966-12-20       Impact factor: 15.419

5.  The purification of human prothrombin.

Authors:  S S Shapiro; D F Waugh
Journal:  Thromb Diath Haemorrh       Date:  1966-12-01

6.  Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles.

Authors:  D Papahadjopoulos; W J Vail; K Jacobson; G Poste
Journal:  Biochim Biophys Acta       Date:  1975-07-03

7.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

8.  Factor X activating enzyme from Russell's viper venom: isolation and characterization.

Authors:  W Kisiel; M A Hermodson; E W Davie
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

9.  The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

10.  Inhibitor-neutralisation assay and electro-immuno assay of human factor IX (Christmas factor).

Authors:  R M Bertina; I K van der Linden
Journal:  Clin Chim Acta       Date:  1977-06-15       Impact factor: 3.786

View more
  16 in total

1.  Regions 301-303 and 333-339 in the catalytic domain of blood coagulation factor IX are factor VIII-interactive sites involved in stimulation of enzyme activity.

Authors:  J A Kolkman; P J Lenting; K Mertens
Journal:  Biochem J       Date:  1999-04-15       Impact factor: 3.857

2.  A3 domain region 1803-1818 contributes to the stability of activated factor VIII and includes a binding site for activated factor IX.

Authors:  Esther Bloem; Henriet Meems; Maartje van den Biggelaar; Koen Mertens; Alexander B Meijer
Journal:  J Biol Chem       Date:  2013-07-24       Impact factor: 5.157

3.  Dissimilar interaction of factor VIII with endothelial cells and lipid vesicles during factor X activation.

Authors:  H J Brinkman; P Koster; K Mertens; J A van Mourik
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Surface-loop residue Lys316 in blood coagulation Factor IX is a major determinant for Factor X but not antithrombin recognition.

Authors:  J A Kolkman; K Mertens
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

5.  Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine.

Authors:  Gary E Gilbert; Valerie A Novakovic; Jialan Shi; Jan Rasmussen; Steven W Pipe
Journal:  Blood       Date:  2015-07-10       Impact factor: 22.113

6.  Kinetics of Factor X activation by the membrane-bound complex of Factor IXa and Factor VIIIa.

Authors:  Mikhail A Panteleev; Evgueni L Saenko; Natalya M Ananyeva; Fazoil I Ataullakhanov
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

7.  The interaction of bovine factor IX, its activation intermediate, factor IX alpha, and its activation products, factor IXa alpha and factor IXa beta, with acidic phospholipid vesicles of various compositions.

Authors:  J M Beals; F J Castellino
Journal:  Biochem J       Date:  1986-06-15       Impact factor: 3.857

8.  The contribution of Ca2+ and phospholipids to the activation of human blood-coagulation Factor X by activated Factor IX.

Authors:  K Mertens; R M Bertina
Journal:  Biochem J       Date:  1984-11-01       Impact factor: 3.857

9.  The association of human coagulation factors VIII, IXa and X with phospholipid vesicles involves both electrostatic and hydrophobic interactions.

Authors:  J S Atkins; P R Ganz
Journal:  Mol Cell Biochem       Date:  1992-05-13       Impact factor: 3.396

10.  The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

Authors:  V J Bom; R M Bertina
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.